BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Dendritic cell immune modulation in cancer patients
DTSTART:20230921T121500
DTEND:20230921T133000
DTSTAMP:20260528T153421Z
UID:743a370aa5f1918344bd23958a9ffd12cd3c64f03d3aae695b637c29
CATEGORIES:Conferences - Seminars
DESCRIPTION:Prof. Dr. Jolanda De Vries\, Radboud University Nijmegen Medic
 al Centre/Nijmegen Centre for Molecular Life Sciences\, Netherlands\nA Lol
 a and John Grace Distinguished Lecture in Cancer Research\n\nProfessor Jol
 anda de Vries is Chair of the Department of Medical Biosciences and Presid
 ent of the Dutch Society of Immunology (DSI/NVVI). She was one of the pion
 eers to translate dendritic cell (DC) biology into potential clinical appl
 ications. The first clinical phase I/II studies in which patients were vac
 cinated with DCs loaded with tumour-specific peptides were initiated in 19
 97. She also developed a novel immuno-monitoring assay that is highly pred
 ictive for extended survival after vaccination with DCs. Her primary scien
 tific interest continues along the line of DC-immunotherapy and in particu
 lar the migration and imaging of DC.\n\nJolanda de Vries did her PhD at th
 e Department of Dermatology of University Medical Centre Utrecht from 1991
 -1997. In 1997\, she joined the Department of Tumor Immunology\, Radboud U
 niversity Nijmegen Medical Centre/Nijmegen Centre for Molecular Life Scien
 ces. By the end of that year\, she was able to provide the first DC-based 
 vaccine for a melanoma patient\, the first patient receiving DCs in the Ne
 therlands\, with a close collaboration with the Departments of Medical Onc
 ology and Hematology.  Over the last 8 years\, a clinical vaccination pro
 gram in which tumor-associated antigens loaded on DCs to treat melanoma pa
 tients\, has been established. Primary scientific interest continues along
  the lines of DC-immunotherapy and in particular the migration and imaging
  of DC.\n\n 
LOCATION:SV 1717 https://plan.epfl.ch/?room==SV%201717 https://epfl.zoom.u
 s/s/97039045251
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR